GlassScriptPhysician profile
John C Julian
NPI 1467457093
$3,560.83
in general payments reported to CMS, 2019-2025
32 companies · $424 in 2025
The $424 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $287 · 2021: $504 · 2022: $330 · 2023: $604 · 2024: $1,024 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,052.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $476.25 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $373.17 | 2020-2025 | Accolade Sr, General - Erectile Dysfunction, Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $333.27 | 2019-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $309.91 | 2021-2025 | Prolaris |
| Sumitomo Pharma America, INC. | $281.24 | 2023-2025 | Orgovyx, Gemtesa |
| Dornier Medtech America, INC | $186.44 | 2024 | Dornier Medtech |
| Pfizer INC. | $169.95 | 2023-2025 | |
| Janssen Biotech, INC. | $155.64 | 2019-2025 | Erleada |
| Coloplast Corp | $141.24 | 2019-2024 | |
| Urogen Pharma, INC. | $109.34 | 2021-2024 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $100.15 | 2019-2025 | |
| Olympus America INC. | $93.94 | 2022-2024 | Itind System |
| Novartis Pharmaceuticals Corporation | $91.10 | 2024-2025 | |
| Accord Healthcare, INC. | $89.07 | 2024 | |
| Urovant Sciences INC | $67.05 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $59.04 | 2020-2022 | |
| Myovant Sciences INC. | $57.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $54.30 | 2022 | |
| Ferring Pharmaceuticals INC. | $50.82 | 2019-2024 | Adstiladrin |
| Antares Pharma, INC. | $45.83 | 2021-2024 | Xyosted |
| Laborie Medical Technologies Corp. | $39.91 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Palette Life Sciences, INC. | $38.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $31.28 | 2023 | Seglentis |
| Amgen INC. | $31.20 | 2021 | |
| Progenics Pharmaceuticals, INC. | $28.02 | 2024 | |
| Immunitybio, INC. | $26.27 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $24.58 | 2024 | Bard Urinary Drainage Bag |
| Tactile Systems Technology INC | $23.79 | 2024 | Entre Plus, Flexitouch Plus |
| Abbvie INC. | $20.18 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $19.35 | 2020 | |
| Baudax Bio INC. | $18.05 | 2021 | |
| Teleflex LLC | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Julian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.